Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy of leukemia.

M K Brenner1, H E Heslop

  • 1Department of Hematology/Oncology, St Jude Children's Research Hospital, Memphis, TN.

Leukemia
|January 1, 1992
PubMed
Summary

The immune system can fight leukemia through T-cells and killer cells. Interleukin 2 and gene marking techniques can enhance this immune response for better leukemia eradication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

A whole blood model of thrombocytopenia that controls platelet count and hematocrit.

Annals of hematology·2016
Same author

Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

Leukemia & lymphoma·2016
Same author

Engineering haploidentical transplants.

Bone marrow transplantation·2015
Same author

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD.

Bone marrow transplantation·2014
Same author

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.

Bone marrow transplantation·2013

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Background:

  • Substantial evidence supports the immune system's role in eradicating leukemia.
  • Mechanisms include alloreactive T-cells post-allogeneic bone marrow transplant (BMT) and leukemia-specific antigen recognition.

Purpose of the Study:

  • To explore various immune-mediated mechanisms for leukemia eradication.
  • To investigate the potential of augmenting these mechanisms with therapies like interleukin 2 and advanced diagnostics.

Main Methods:

  • Review of existing evidence on immune effector mechanisms in leukemia.
  • Discussion of the role of T-cells, natural killer/activated killer cells.
  • Exploration of therapeutic augmentation strategies and diagnostic advancements.

Main Results:

  • Alloreactive T-cells and leukemia-specific T-cells are key players.
  • Natural killer/activated killer cells contribute through MHC-unrestricted, leukemia-selective killing.
  • Interleukin 2 can enhance effector mechanisms post-chemotherapy or autologous BMT.
  • Gene marking aids in identifying minimal residual disease for targeted immune therapy.

Conclusions:

  • The immune system offers multiple avenues for leukemia eradication.
  • Therapeutic interventions like IL-2 and diagnostic tools like gene marking show promise in enhancing anti-leukemia immunity.

Related Experiment Videos